Search by Drug Name or NDC
NDC 70515-0501-10 Sular 17 mg/1 Details
Sular 17 mg/1
Sular is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Covis Pharma US, Inc. The primary component is NISOLDIPINE.
MedlinePlus Drug Summary
Nisoldipine is used to treat high blood pressure. Nisoldipine is in a class of medications called calcium channel blockers. It works by relaxing your blood vessels so your heart does not have to pump as hard. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 70515-0501-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Nisoldipine
Product Information
| NDC | 70515-0501 |
|---|---|
| Product ID | 70515-501_b1f33d4e-acf6-4b44-af7d-83829b7fc808 |
| Associated GPIs | 34000024007517 |
| GCN Sequence Number | 063731 |
| GCN Sequence Number Description | nisoldipine TAB ER 24H 17 MG ORAL |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 99446 |
| HICL Sequence Number | 008268 |
| HICL Sequence Number Description | NISOLDIPINE |
| Brand/Generic | Brand |
| Proprietary Name | Sular |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | nisoldipine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 17 |
| Active Ingredient Units | mg/1 |
| Substance Name | NISOLDIPINE |
| Labeler Name | Covis Pharma US, Inc |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020356 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70515-0501-10 (70515050110)
| NDC Package Code | 70515-501-10 |
|---|---|
| Billing NDC | 70515050110 |
| Package | 1 BOTTLE in 1 CARTON (70515-501-10) / 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE |
| Marketing Start Date | 2017-02-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |